Tilray hit its 52-week low earlier this week as the DEA hearing to reschedule cannabis was temporarily paused. Tilray will report Q1-2027 revenue next week and expects an increase in revenue YoY.
Bringing you TOP Pot Stocks!
Tilray hit its 52-week low earlier this week as the DEA hearing to reschedule cannabis was temporarily paused. Tilray will report Q1-2027 revenue next week and expects an increase in revenue YoY.
Copyright © 2026 Cannabis Stocks News
Recent Comments